Back

Athernal Bio wins nearly £700,000 Innovate UK grant for leukaemia interception

Verifying
  • Athernal Bio received an Innovate UK grant to advance its lead leukaemia-interception immunotherapy.
  • Nearly £700,000 will fund preclinical studies validating Athernal’s lead candidate.
  • Innovate UK’s programme has awarded £168 million to more than 400 UK businesses since 2017.
The information on this website is generated using AI and we cannot guarantee its accuracy. Please use it as reference information only.